# Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease

> **NCT03515213** · PHASE2 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 10 (actual)

## Conditions studied

- Huntington Disease

## Interventions

- **DRUG:** Fenofibrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03515213
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-27
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03515213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03515213, "Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03515213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*